Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
MBX Capital, formerly known as FundRx, is an early-stage venture capital firm founded in 2021 and headquartered in New York, NY, with an additional office in Washington, D.C. The firm focuses on investing in visionary founders within the deep health sector, emphasizing a concentrated investment approach. MBX Capital collaborates with a network of scientific and clinical experts to source and vet investments, ensuring a thorough diligence process.
As of now, MBX Capital manages a portfolio of 20 companies, primarily in the healthcare, biotech, and medical device sectors. The firm has evolved from its earlier model of smaller checks to a more concentrated ownership approach, targeting investments ranging from $1 million to $4 million. This shift reflects a commitment to advancing healthcare technology and services through innovative solutions.
MBX Capital's notable milestones include the rebranding from FundRx to MBX Capital, which signifies a strategic focus on deep health innovations. The firm has established a reputation for supporting early-stage companies that address complex healthcare challenges through advanced technologies.
MBX Capital invests in early-stage companies primarily within the deep health sector, targeting innovative solutions in drug formulation, chronic disease detection, genetic testing, and mental healthcare. The firm typically engages with companies in their pre-seed, seed, and seed-plus stages, focusing on those that have not yet reached a $50 million valuation. Investment amounts generally range from $1 million to $4 million, with a target of at least 5% ownership in each company.
The firm emphasizes collaboration with co-investors and leverages its extensive network of scientific and clinical experts to drive advancements in healthcare technology. MBX Capital seeks founders who possess a clear vision for making a significant impact in deep health, and it values innovative approaches that address pressing healthcare challenges. Their investment strategy is designed to foster partnerships that enhance the potential for successful outcomes in the healthcare landscape.
MBX Capital's portfolio includes a diverse range of companies focused on healthcare innovation. Notable portfolio companies include:
Gurdane Bhutani: Managing Partner. Gurdane has extensive experience in venture capital and healthcare investments, having previously worked with various firms focused on healthcare innovation.
Zeshan Muhammedi: Founder & Managing Partner. Zeshan was the CEO of FundRx and has a strong background in venture capital, particularly in the healthcare sector. He is also associated with Synergy Capital Investments LLC.
To pitch MBX Capital, founders should use the contact email team@mbxcapital.com. It is recommended to include a detailed deck that outlines the business model, market opportunity, and the team’s qualifications. Founders should expect a response within a few weeks, and warm introductions are preferred but not mandatory.
In 2025, MBX Capital has made significant investments in AI and robotics for drug formulation, engineered receptors for cell signaling, and IVF preimplantation genetic testing. In 2024, the firm focused on AI for chronic disease detection, green chemistry solutions, and infrastructure for infusion therapy. In 2023, MBX Capital invested in organoids-on-a-chip technology for toxicology and peer support services.
The firm continues to expand its portfolio, reflecting its commitment to supporting visionary founders in the healthcare sector. The rebranding from FundRx to MBX Capital marks a strategic shift towards a concentrated investment approach in deep health innovations.
What are MBX Capital's investment criteria?
MBX Capital focuses on early-stage companies in the deep health sector, particularly those addressing complex healthcare challenges through innovative technologies. They typically invest in companies at the pre-seed, seed, and seed-plus stages.
How can founders apply or pitch to MBX Capital?
Founders can pitch to MBX Capital by visiting their website at mbxcapital.com and using the contact email team@mbxcapital.com for inquiries. A clear vision for making a deep health impact is essential.
What makes MBX Capital different from other venture capital firms?
MBX Capital distinguishes itself through its concentrated investment approach and collaboration with a network of scientific and clinical experts. This network aids in sourcing and vetting investments, enhancing the diligence process.
What is the geographic scope of MBX Capital's investments?
While MBX Capital primarily invests in North America, they are open to opportunities globally, particularly in the healthcare sector.
What is the typical check size for investments?
MBX Capital typically invests between $1 million and $4 million in each portfolio company, aiming for at least 5% equity ownership.
What kind of post-investment involvement does MBX Capital have?
MBX Capital provides not only capital but also insights and guidance to portfolio companies, facilitating strategic partnerships and collaborations to navigate the complex healthcare landscape.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.